Bausch + Lomb Corporation (BLCO) — Stock Score Summary

Bausch + Lomb Corporation (BLCO) has a MoatMap StockRank of 66/100 based on Quality (43/100), Value (46/100), and Momentum (60/100) factor scores. The current signal is BUY. Bausch + Lomb is a global eye health company. It is burdened by high debt from its spin-off and lacks any structural alignment with our high-conviction macro themes.

Bausch + Lomb Corporation is a leading global eye health company that develops, manufactures, and markets a comprehensive portfolio of contact lenses, ophthalmic pharmaceuticals, and surgical devices. The company commands a powerful competitive moat built on over 170 years of brand heritage, extensive global distribution, and a highly diversified product suite. It is well-positioned to benefit from secular tailwinds in global eye care driven by an aging population and increasing digital screen usage.

Key Financial Metrics

Price$15.65
Market Cap$5.6B
P/E (Forward)14.27
Price/Book0.86
Return on Equity-3.3%
Return on Invested Capital0.9%
Debt/Equity78.58
Gross Margin60.6%
Operating Margin4.7%
Revenue Growth9.4%
Free Cash Flow$239M

Bausch + Lomb Corporation operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (Canada).

Frequently Asked Questions

What is Bausch + Lomb Corporation’s (BLCO) StockRank?
MoatMap’s StockRank for Bausch + Lomb Corporation (BLCO) is 66/100, with a Buy signal. It is a composite of Quality (43), Value (46), and Momentum (60) factor ranks across MoatMap’s 19,000+ stock universe.
Does Bausch + Lomb Corporation have an economic moat?
Bausch + Lomb Corporation (BLCO) has a Quality factor score of 43/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Bausch + Lomb Corporation a buy, hold, or sell?
MoatMap’s current signal for Bausch + Lomb Corporation (BLCO) is Buy, based on a StockRank of 66/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Bausch + Lomb Corporation in?
Bausch + Lomb Corporation (BLCO) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (Canada).
Browse all ranked stocksBLCO deep dive reportAI ChampionsHow we score stocksSense-check another stock